Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Dicloxacillin
Drug ID BADD_D00657
Description One of the penicillins which is resistant to penicillinase.
Indications and Usage Used to treat infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug.
Marketing Status approved; investigational; vet_approved
ATC Code J01CF01
DrugBank ID DB00485
KEGG ID D02348
MeSH ID D004009
PubChem ID 18381
TTD Drug ID D0R2KJ
NDC Product Code Not Available
UNII COF19H7WBK
Synonyms Dicloxacillin | Dicloxacycline | Dichloroxacillin | Dicloxaciclin | Diclocil | Dicloxacillin Sodium | Sodium, Dicloxacillin | Dicloxacillin, Monosodium Salt, Mono-Hydrate | Dicloxacillin, Monosodium Salt, Anhydrous | Dicloxsig | Distaph | Dycill | Dynapen | InfectoStaph | Pathocil | Posipen | Cilpen | Ditterolina
Chemical Information
Molecular Formula C19H17Cl2N3O5S
CAS Registry Number 3116-76-5
SMILES CC1=C(C(=NO1)C2=C(C=CC=C2Cl)Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)O
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal discomfort07.01.06.001---
Abdominal pain07.01.05.002--
Agranulocytosis01.02.03.001---
Alanine aminotransferase increased13.03.04.005--
Anaemia01.03.02.001--
Anaphylactic shock10.01.07.002; 24.06.02.004---
Angioedema10.01.05.009; 22.04.02.008; 23.04.01.001---
Arthralgia15.01.02.001--
Aspartate aminotransferase increased13.03.04.011--
Body temperature increased13.15.01.001---
Bone disorder15.02.04.004---
Bronchospasm10.01.03.012; 22.03.01.004--
Confusional state17.02.03.005; 19.13.01.001--
Dermatitis23.03.04.002---
Diarrhoea07.02.01.001--
Discomfort08.01.08.003---
Dyspepsia07.01.02.001--
Eosinophilia01.02.04.001--
Epilepsy17.12.03.002---
Feeling abnormal08.01.09.014---
Flatulence07.01.04.002--
Gastrointestinal disorder07.11.01.001---
Gastrointestinal pain07.01.05.005--
Haematuria20.02.01.006; 21.10.01.018; 24.07.01.047--
Haemolytic anaemia01.06.03.002---
Hepatitis cholestatic09.01.01.002---
Hepatotoxicity09.01.07.009; 12.03.01.008---
Hypersensitivity10.01.03.003--
Hypotension24.06.03.002--
Laryngeal oedema10.01.05.003; 22.04.02.001; 23.04.01.005--
The 1th Page    1 2 3    Next   Last    Total 3 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene